Recombinant Human GPR56 Protein (HEK293)

GPR56, a member of the G protein-coupled receptor (GPCR) family, has garnered significant interest in recent years due to its role in various physiological processes and its implications in several diseases. Originally identified as a receptor involved in the regulation of cell adhesion and migration, GPR56 plays a crucial role in brain development, particularly in the formation and organization of the cerebral cortex. Mutations in the GPR56 gene have been linked to developmental disorders, particularly in a rare neurodevelopmental condition known as bilateral frontoparietal polymicrogyria, highlighting its importance in neurogenesis. Furthermore, GPR56 has been implicated in cancer biology, where its expression levels can influence tumor progression and metastasis in several cancer types. As a result, the exploration of GPR56 recombinant proteins has become a focal point for researchers aiming to elucidate its functional mechanisms and potential therapeutic applications. The generation of recombinant GPR56 allows for detailed structural and functional studies, enabling the assessment of its ligand interactions and signaling pathways. This research not only enhances our understanding of GPR56's biological roles but also opens avenues for the development of targeted therapies that could modulate its activity in pathological conditions, making it a promising candidate for drug discovery and development in the fields of neurology and oncology.